NIP
BMY icon

Nicholas Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Nicholas Investment Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-21,349
Closed -$1.16M – 246
2017
Q1 		$1.16M Buy
+21,349
New +$1.17M 0.08% 236
2016
Q3 		– Sell
-35,860
Closed -$2.64M – 299
2016
Q2 		$2.64M Buy
35,860
+16,476
+85% +$1.16M 0.18% 227
2016
Q1 		$1.24M Buy
+19,384
New +$1.22M 0.09% 272
2014
Q2 		– Sell
-47,580
Closed -$2.47M – 275
2014
Q1 		$2.47M Buy
+47,580
New +$2.53M 0.2% 175

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nicholas Investment Partners's BMY Position: Q2 2017 in Review

Nicholas Investment Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2017, closing a stake of 21,349 shares — an estimated $1.16M sold.

Nicholas Investment Partners first reported a position in BMY in Q1 2014 and held it in 4 quarters. The position peaked at $2.64M in Q2 2016. 1,594 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

  • Nicholas Investment Partners reported no remaining Bristol-Myers Squibb position as of Q2 2017 after selling out during the quarter.
  • Nicholas Investment Partners sold 21,349 Bristol-Myers Squibb shares in Q2 2017, an estimated $1.16M.
  • Nicholas Investment Partners first reported a position in Bristol-Myers Squibb in Q1 2014 and held it in 4 quarters.
  • Nicholas Investment Partners's Bristol-Myers Squibb position peaked at $2.64M in Q2 2016.
  • 1,594 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on Nicholas Investment Partners's 13F filing for Q2 2017, filed 11 Aug 2017.